Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anne Löhr"'
Publikováno v:
Zeitschrift Hochschule und Weiterbildung, Vol 2022, Iss 1 (2022)
Das Forschende Lernen hat sich als ein aktivierender Ansatz der Erwachsenenbildung im Rahmen der wissenschaftlichen Weiterbildung Älterer an verschiedenen Universitäten im Kontext des Senior*innenstudiums etabliert. In diesem Beitrag werden an Hand
Externí odkaz:
https://doaj.org/article/b661efdc6afc4e6c83445f75c48bc003
Autor:
Simone Gaedicke, Gabriele Niedermann, Anne Grote, Friedrich Feuerhake, Eva Oswald, Kanstantsin Lashuk, Daniel Bug, Nassim Bouteldja, Dorothee Lenhard, Anne Löhr, Anke Behnke, Volker Knauff, Anna Edinger, Kerstin Klingner, Dorit Merhof, Julia Schueler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/6d293a6cd46e42e59c4af0d350d0d410
Autor:
Eva Oswald, Julia Schüler, Stefanie Schmitt, Anne-Lise Peille, Dorothee Lenhard, Volker Knauff, Anna Edinger, Anke Behnke, Anne Löhr
Publikováno v:
Cancer Research. 79:1057-1057
Model selection is one critical step in anti-cancer drug development. In the advent of immune modulatory compounds being part of most of the oncology drug development pipelines, the available preclinical models have to be characterized with respect t
Autor:
Anne Loehr, Jezra Kaye
Who changed the rules of business?It's a different game now. In an increasingly globally diverse workforce, it's vitally important that leaders understand their team inside and out. This takes a new toolbox of skills for the 21st century. Today you n
Autor:
Teppo Haapaniemi, Cordula Tschuch, Kerstin Klingner, Anne Löhr, Julia Schüler, Yana Raeva, Eva Oswald
Publikováno v:
Cancer Research. 76:590-590
Nowadays, an increasing number of monoclonal antibodies (mAbs) that specifically target malignant cells or interfere with different compartments of the tumor microenvironment are available for cancer therapy. They take effect via different modes of a
Autor:
Yana Raeva, Cordula Tschuch, Kerstin Klingner, Anne Löhr, Eva Oswald, Anne-Lise Peille, Julia Schüler, Dorothee Lehnhard
Publikováno v:
Molecular Cancer Therapeutics. 14:A10-A10
Non-small cell lung cancer (NSCLC) is the largest subgroup of lung cancer, occurring at a frequency of over 80% of lung cancer cases. In up to 30% of NSCLC patients the oncogenic driver of tumor growth is a constitutively activated EGF receptor (EGFR
Autor:
Anne Loehr, Brian Emerson
To stay on top, companies need to do more than just tread water—they need to grow. And that means that their employees need to develop and improve their skills at the same pace. More than ever, managers are being encouraged to improve employee perf